Interferon alfa-2b biosimilar (Laboratorios Bioprofarma)

干扰素α-2b生物类似药 (Laboratorios Bioprofarma)

Report date: 2023/05/05 17:35:05

Base Information

Drug NameInterferon alfa-2b biosimilar (Laboratorios Bioprofarma)
Drug Alias Name干扰素α-2b生物仿制药 (Laboratorios Bioprofarma)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMelanomaLymphoma, FollicularLeukemia, Hairy Cell +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Bioprofarma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Bioprofarma
Inactive CompaniesN/A
Active IndicationsMelanomaLymphoma, FollicularLeukemia, Hairy Cell +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A